8D9-29507-03429
2 vaccinations
2 coded responses
15 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 551 / MN
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-01
- 2021-04-02
-
2021-04-03
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-04
- 2021-07-01
- 2021-10-01
-
2021-12-23
Dose 2 — Pfizer-BioNTech
- 2021-12-23
-
2021-12-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-25
- 2021-12-26
- 2021-12-27
- 2021-12-28
- 2021-12-29
- 2021-12-30
-
2022-01-08
Survey response — day 14, dose 2MedDRA: Influenza like illness — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Flu like symptomsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-23 | Pfizer-BioNTech | No |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat
Release 10 — day 14, dose 2
Symptoms: Flu like symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza like illness | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release